Endarterectomy vs. Stenting in Asymptomatic Carotid Artery Stenosis

The comparative efficacy and safety of carotid stenting vs. endarterectomy in asymptomatic carotid stenosis patients remains controversial and, what is worse, consensus seems unlikely in the near future. Given the lack of definite evidence, several meta-analyzis and systematic reviews have been produced in an attempt to shed some light on this matter.

Enfermedad carotidea asintomática: ¿Endarterectomía o angioplastia?

This study included all controlled and randomized trials comparing both techniques in asymptomatic patients using a pre-specified protocol.

 

Five controlled studies met the inclusion criteria, adding up more than 3,000 patients.


Read also: New Strategies for the Femoropopliteal Artery”.


The pooled incidence of any periprocedural stroke (RR 1.84; CI 95%, 0.99–3.40), periprocedural nondisabling stroke (RR 1.95; CI 95%, 0.98 – 3.89) and any periprocedural stroke or death (RR 1.72; CI 95%, 0.95 – 3.11) show a tendency against stenting. This tendency was observed in periprocedural events, with no difference in stroke at long term (RR 1.24; CI 95%, 0.76 – 2.03) or with the composite of periprocedural stroke, death, MI or ipsilateral stroke at long term (RR 0.92; IC 95%, 0.70–1.21).

 

Conclusion

The best revascularization technique for patients with asymptomatic carotid stenosis continues to be a matter of debate, despite the higher incidence of periprocedural stroke against stenting seems to tilt the scales in favor of endarterectomy.

 

Editorial Comment

The estimated risk of ipsilateral stroke for asymptomatic patients with a ≥50% stenosis to the internal carotid artery is as low as 0.5 or 1% per year. Hence, in order to show the benefits of revascularization, if any, we would need long term follow up.


Read also: Diabetics’ Silent Ischemia Myth Busted”.


The best medical treatment should be prescribed to these patients, but randomized studies comparing stenting vs. endarterectomy were carried out mostly between 1980 and 2000. Without a shadow of a doubt, current medical treatments are highly superior to any medical treatment two decades old, which is why we should consider a third option to treat these patients, one that the original studies had not considered.

 

At present, there are two randomized studies in progress (SPACE-II y CREST-II) that will provide valuable data on the comparative safety and efficacy of the best medical treatment vs. stenting + the best medical treatment vs. endarterectomy + the best medical treatment.

 

Original title: Carotid Stenting Versus Endarterectomy for Asymptomatic Carotid Artery Stenosis. A Systematic Review and Meta-Analysis.

Reference: Paola Moresoli et al. Stroke. 2017 Aug;48(8):2150-2157.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

ACC 2026 | SirPAD Trial: Sirolimus-coated balloon angioplasty in infrainguinal arterial disease

Paclitaxel-coated balloons have demonstrated improved patency in peripheral arterial disease (PAD), although questions remain regarding safety and applicability across different vascular territories. In this...

ACC 2026 | HI-PEITHO: Catheter-directed strategy (EKOS) in intermediate-risk acute pulmonary embolism

The treatment of intermediate-risk pulmonary embolism (PE) continues to be an area of therapeutic uncertainty. The initial PEITHO study (2014) demonstrated a reduction in...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...